Elzbieta Krysiak-Mitka
Dabrowa Gornicza, SL 41300, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Subtype-Independent Activation of NF-κB Signaling in Breast Cancer.
Journal: International journal of molecular sciences
Published: March 30, 2026
Multi-Level Profiling of MAPK-Associated Genes and MicroRNAs Uncovers Regulatory Networks in Breast Cancer Subtypes.
Journal: International journal of molecular sciences
Published: November 10, 2025
Correction to: Subtype-specific dysregulation of biogenic amine-related genes and miRNAs in breast cancer: identification of DRD2, HRH2, and HRH4 as potential therapeutic targets in TNBC and HER2 + subtypes.
Journal: Breast cancer research and treatment
Published: September 05, 2025
Hippo Signaling Dysregulation in Breast Cancer: Subtype-Independent Gene and miRNA Signatures.
Journal: Biomedicines
Published: September 02, 2025
Subtype-specific dysregulation of biogenic amine-related genes and miRNAs in breast cancer: identification of DRD2, HRH2, and HRH4 as potential therapeutic targets in TNBC and HER2+ subtypes.
Journal: Breast cancer research and treatment
Published: March 06, 2025
MAPK-related mRNA and miRNA Expression in LPS-treated Keratinocytes: Implications for Psoriasis Inflammation.
Journal: Current pharmaceutical biotechnology
Published: February 20, 2025
Corrigendum: Distinct mRNA expression profiles and miRNA regulators of the PI3K/AKT/mTOR pathway in breast cancer: insights into tumor progression and therapeutic targets.
Journal: Frontiers in oncology
Published: February 17, 2025
Distinct mRNA expression profiles and miRNA regulators of the PI3K/AKT/mTOR pathway in breast cancer: insights into tumor progression and therapeutic targets.
Journal: Frontiers in oncology
Published: October 22, 2024
Showing 1-9 of 9
Last Updated: 09/26/2026